{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:41:58Z","timestamp":1778629318867,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.ymgme.2005.02.008","type":"journal-article","created":{"date-parts":[[2005,4,4]],"date-time":"2005-04-04T10:28:51Z","timestamp":1112610531000},"page":"236-238","source":"Crossref","is-referenced-by-count":29,"title":["An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum"],"prefix":"10.1016","volume":"85","author":[{"given":"Doug A.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary J.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Litsa","family":"Karageorgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leanne K.","family":"Hein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn F.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2005.02.008_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2005.02.008_bib2","series-title":"The metabolic and molecular basis of inherited diseases","first-page":"3421","article-title":"The mucopolysaccharidosis","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2005.02.008_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0003-2697(82)90674-1","article-title":"High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidosis","volume":"119","author":"Hopwood","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2005.02.008_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5694\/j.1326-5377.1982.tb132293.x","article-title":"Enzymatic diagnosis of the mucopolysaccharidoses: experience of 96 cases diagnosed in a five-year period","volume":"1","author":"Hopwood","year":"1982","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ymgme.2005.02.008_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/bj0780151","article-title":"Studies on glucosaminidase. 4. The fluorometric assay of N-acetyl-\u03b2-glucosaminidase","volume":"78","author":"Leaback","year":"1961","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2005.02.008_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/bmmb.1994.1058","article-title":"Immunochemical characterization of feline and human N-acetylgalactosamine4-sulfatase","volume":"53","author":"Brooks","year":"1994","journal-title":"Biochem. Med. Metab. Biol."},{"key":"10.1016\/j.ymgme.2005.02.008_bib7","first-page":"710","article-title":"Analysis of N-acetylgalactosamine 4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients","volume":"48","author":"Brooks","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2005.02.008_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/bj2680379","article-title":"Human N-acetylgalactosamine-4-sulphatase biosynthesis and maturation in normal, Maroteaux\u2013Lamy and multiple-sulphatase-deficient fibroblasts","volume":"268","author":"Taylor","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2005.02.008_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/humu.10313","article-title":"Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy","volume":"23","author":"Karageorgos","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2005.02.008_bib10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1042\/bj2480755","article-title":"Human N-acetylgalactosamine 4-sulphate sulphatase: purification, monoclonal antibody production and native and subunit Mr values","volume":"248","author":"Gibson","year":"1987","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2005.02.008_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/humu.1190","article-title":"Mucopolysaccharidosis type VI: structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase","volume":"18","author":"Litjens","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2005.02.008_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI935","article-title":"Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes","volume":"101","author":"Crawley","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2005.02.008_bib13","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1074\/jbc.273.22.13421","article-title":"Mild feline mucopolysaccharidosis type VI: identification of an N-acetylgalactosamine-4-sulfatase mutation causing instability and increased specific activity","volume":"273","author":"Yogalingam","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2005.02.008_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome)","volume":"144","author":"Harmatz","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2005.02.008_bib15","first-page":"582","article-title":"A phase I\/II study of enzyme replacement therapy (ERT) for mucopolysaccharisosis VI (MPS VI; Maroteaux\u2013Lamy syndrome): 48 week progress report","volume":"71","author":"Harmatz","year":"2002","journal-title":"Am. J. Hum. Genet."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719205000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719205000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T13:42:35Z","timestamp":1586180555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719205000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S1096719205000752"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2005.02.008","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}